Stockscreener 앱 받기
4.229
4.39%
0.229
Bionano Genomics Inc 주식(BNGO)의 최신 뉴스
Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results - ADVFN
Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025 - ADVFN
Bionano Genomics (BNGO) Projects Stable Revenue Growth for 2025 - GuruFocus
Bionano Genomics (BNGO) Sees Revenue Upgrade Despite Lower Price Target - GuruFocus
Bionano Genomics (BNGO) Faces Revenue Growth, Missed EPS Targets - GuruFocus
Bionano Genomics (BNGO) Advances Multiple Myeloma Analysis - GuruFocus
Bionano Genomics (BNGO) Reports Q4 2024 Earnings: Revenue Decline but Margin Improvement - GuruFocus
HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BMV:BNGO) with Buy Recommendation - Nasdaq
HC Wainwright & Co. Initiates Coverage of Bionano Genomics (LSE:0A4K) with Buy Recommendation - Nasdaq
HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BNGO) with Buy Recommendation - Nasdaq
HC Wainwright Initiates Bionano Genomics With Buy Rating, $10 Price Target - marketscreener.com
Richardson Electronics Q3 2025 Earnings Call Transcript - MarketBeat
Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM - The Manila Times
Breakthrough: French Study Reveals Game-Changing Multiple Myeloma Detection Method - Stock Titan
(BNGO) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Revenues Working Against Bionano Genomics, Inc.'s (NASDAQ:BNGO) Share Price Following 26% Dive - simplywall.st
Bionano Genomics Inc Reports Q4 Revenue of $8.2 Million, Surpassing Estimates - GuruFocus
Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest Results - Yahoo Finance
Bionano Genomics Q4 Earnings Call: Mixed Sentiments and Strategic Shifts - TipRanks
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2024 Earnings Call Transcript - Insider Monkey
Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... - Yahoo Finance
Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... By GuruFocus - Investing.com Canada
Bionano Genomics Reports 2024 Financial Results - TipRanks
Bionano Genomics outlines 2025 revenue guidance of $29M-$32M with strategic focus on utilization - MSN
Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript - Yahoo Finance
Bionano Genomics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Bionano Genomics Q4 2024 sees revenue drop By Investing.com - Investing.com South Africa
Earnings call transcript: Bionano Genomics Q4 2024 sees revenue drop - Investing.com
Bionano Genomics, Inc. SEC 10-K Report - TradingView
Bionano Genomics Reports Q4 and Full-Year 2024 Results - TradingView
Stock Market Correction: 2 Warren Buffett Stocks to Buy Hand Over Fist - The Globe and Mail
Bionano Genomics Inc expected to post a loss of $6.00 a shareEarnings Preview - TradingView
SoFi Stock Is Down 23% YTD. Should You Buy the Dip or Stay Away? - The Globe and Mail
What's Next: Bionano Genomics's Earnings Preview - Benzinga
Q4 Earnings Outperformers: Fastenal (NASDAQ:FAST) And The Rest Of The Maintenance and Repair Distributors Stocks - The Globe and Mail
Hakluyt appoints Ronald Sugar to its International Advisory Board - The Globe and Mail
BNGO stock touches 52-week low at $3.15 amid market challenges By Investing.com - Investing.com South Africa
BNGO stock touches 52-week low at $3.15 amid market challenges - Investing.com Australia
LYFT Stock Gains as Activist Investor Engine Capital Builds Stake - The Globe and Mail
Bionano Genomics and Greenwood Genetic Center Publish Study Using Optical Genome Mapping to Advance Understanding of Neural Tube Defects - Nasdaq
Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect - The Manila Times
Major Discovery: New Genes Linked to Birth Defects Found Using Advanced DNA Mapping - StockTitan
3 Services Stocks Skating on Thin Ice - The Globe and Mail
BNGO stock touches 52-week low at $3.28 amid market challenges - Investing.com Australia
BNGO stock touches 52-week low at $3.28 amid market challenges By Investing.com - Investing.com South Africa
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting - The Manila Times
Leading Experts Validate Bionano's Genome Mapping Technology at Major Medical Conference - StockTitan
(BNGO) Technical Data - Stock Traders Daily
Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025 - The Manila Times
1.20%
자본화:
|
볼륨(24시간):